Inogen Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
32.0%projected annual EPS growth
Analyst Coverage
3analysts covering
FY Revenue (est.)
$356.5Mnext fiscal year
FY EPS (est.)
-$0.28next fiscal year
Monitoring Framework
Key Performance Indicators
Total Revenue Quarterly85.1MTarget: 366000000 to 373000000
Adjusted EBITDA Quarterly-1.4MTarget: Positive improvement for full year 2026
Cash, Cash Equivalents, Marketable Securities, and Restricted Cash Quarterly111.5MTarget: Maintain strong liquidity with no debt outstanding
Watch Items
- U.S. Rentals Revenue and Channel MixTrigger: Continued decline in U.S. rentals due to reimbursement mix and reduced patients on serviceAction: Optimize commercial execution and expand HME relationships to offset rental headwinds
- International POC Sales GrowthTrigger: Slowing of international growth below double-digitsAction: Deepen relationships with international HMEs, pursue new tenders, and expand Eastern Europe, Latin America, and APAC footprints
- Product Diversification ExecutionTrigger: Slower-than-expected adoption of Simeox, Voxi 5, or Aurora CPAP masksAction: Increase clinical evidence work, R&D investments, and targeted commercial spending to drive pull-through
Research as of 20 Jun 2026